White Paper

Digital Pathology: Software Applications and Business Incentives in Preclinical Drug Development

Did you know there will be a 16% increase in demand for U.S. pathologists by 2030? Due to a decline in the pathologist workforce, there is currently a risk in meeting the increasing demand for toxicological pathology studies.

Access our free white paper, Digital Pathology: Software Applications and Business Incentives in Preclinical Drug Development, and discover how leading pathologists are meeting increasing demand by saving time and optimizing pathology processes with a digital pathology system.

Download the White Paper

Trusted by the Most Reputable Brands in the World

Download the white paper to find out how
Digital Pathology can accelerate pathological studies.